The Department of Health & Human Services has decided to pause its plans for a rebate program tied to the 340B Drug Discount Program. This program helps hospitals buy outpatient drugs at reduced prices. Initially, the department wanted to set up a trial where hospitals would buy these drugs at full price and then receive rebates later. However, many hospitals expressed concerns about the financial strain this would create while they waited for the rebates.
In a recent legal case, hospitals in Maine successfully stopped this program, which was set to launch soon. The Health Department confirmed it will not continue the legal battle and is putting the rebate program on hold for now. However, they hinted at the possibility of revisiting the idea in the future.
Rick Pollack, CEO of the American Hospital Association, welcomed the decision, noting the need to rethink the program. Hospitals stressed that such changes needed careful consideration to avoid putting additional financial pressure on them. The challenges of the rebate model included a lengthy wait for funds while bearing upfront costs.
Jennifer DeCubellis, from America’s Essential Hospitals, highlighted the drawbacks of the rebate model, saying it would increase the administrative burden on hospitals without guaranteeing timely reimbursement.
Currently, over 2,700 hospitals participate in the 340B program, which has seen costs balloon over the years. In fact, spending on the program soared to $43.9 billion in 2021, a significant rise from just $6.4 billion in 2010. Critics argue that the program has evolved beyond its initial purpose, which was to support safety-net hospitals.
Experts emphasize the importance of affordable medication access. Jerry Penso, CEO of the American Medical Group Association, termed the suspension a victory for both patients and providers. As healthcare continues to evolve, the focus remains on striking a balance that helps hospitals while ensuring patients receive the care they need.
For more information on the changes in the 340B Drug Discount Program, you can read the Congressional Budget Office report.
